T 0115/13 (Discriminatory diagnosis of tuberculosis/RUTGERS) of 11.04.2018
- European Case Law Identifier
- ECLI:EP:BA:2018:T011513.20180411
- Date of decision
- 11 April 2018
- Case number
- T 0115/13
- Petition for review of
- -
- Application number
- 00928851.5
- IPC class
- C12N 1/00A61K 39/04A61K 39/00C12P 21/06C07H 21/02C07H 21/04C07K 1/00A61K 38/00A61K 39/02C12N 1/12
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PROTEINS EXPRESSED BY MYCOBACTERIUM TUBERCULOSIS AND NOT BY BCG AND THEIR USE AS DIAGNOSTIC REAGENTS AND VACCINES
- Applicant name
- Rutgers, the State University of New Jersey
- Opponent name
- GlaxoSmithKline Biologicals SA
Statens Serum Institut - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention R 115(2)Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 15(3)
- Keywords
- Summons to oral proceedings - non-attendance of party
Late-filed evidence
Late-filed request - submitted with the statement of grounds of appeal
Inventive step - (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.